JP Morgan Chase
WGS icon

JP Morgan Chase’s GeneDx Holdings WGS Stock Holding History

JP Morgan Chase’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,000
Closed -$974K – 7693
2025
Q1 		$974K Buy
+11,000
New +$954K ﹤0.01% 4368

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

JP Morgan Chase's WGS Position: Q2 2026 in Review

JP Morgan Chase increased its GeneDx Holdings (WGS) stake by 62% in Q2 2026, buying an estimated $1.18M and bringing the position to 54,387 shares worth $3.84M. The position accounts for ﹤0.01% of the portfolio, ranked #3683.

JP Morgan Chase first reported a position in WGS in Q4 2020 and has held it in 20 quarters since. The position peaked at $8.29M in Q4 2024. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • JP Morgan Chase held 54,387 shares of GeneDx Holdings worth $3.84M as of Q2 2026.
  • JP Morgan Chase bought 20,713 GeneDx Holdings shares in Q2 2026, an estimated $1.18M.
  • GeneDx Holdings made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3683 holding.
  • JP Morgan Chase first reported a position in GeneDx Holdings in Q4 2020 and has held it in 20 quarters since.
  • JP Morgan Chase's GeneDx Holdings position peaked at $8.29M in Q4 2024.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.